Low Dose Immunotherapy

Low Dose Immunotherapy (LDI) uses micro-doses of specific antigens to retrain the immune system and promote tolerance rather than reactivity. This approach reduces inappropriate immune responses causing inflammation and autoimmune conditions. Benefits include relief from food and environmental allergies, reduced chronic inflammation, and immune system rebalancing. LDI treats conditions like Lyme disease, fibromyalgia, chronic fatigue, inflammatory bowel disease, arthritis, and various allergies and sensitivities. Treatment is highly individualized, requiring progressive dosing to identify effective antigens and strength levels. Unlike vaccines, LDI calms overactive immune responses rather than stimulating them, addressing root triggers of chronic inflammatory and autoimmune disorders through personalized therapeutic protocols.